Skip to content
You are not authorized to view this resource.
You need to login.
Please update your
to view content.
Sagent Pharmaceuticals Announces the Launch of GLYDO(TM) (Lidocaine HCI Jelly USP, 2%)
Sagent Pharmaceuticals Announces the Introduction of Oxaliplatin Injection, USP
Sagent Pharmaceuticals Announces the Launch of Ketorolac Tromethamine Injection, USP
SAGENT PHARMACEUTICALS, SAGENT, INJECTABLES EXCELLENCE and DISCOVER INJECTABLES EXCELLENCE
are trademarks of Sagent Pharmaceuticals, Inc.©2007-2014 Sagent Pharmaceuticals, Inc.